Compare BYND & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BYND | EMBC |
|---|---|---|
| Founded | 2009 | 1924 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Medical/Dental Instruments |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 231.6M | 199.9M |
| IPO Year | 2018 | 2021 |
| Metric | BYND | EMBC |
|---|---|---|
| Price | $14.77 | $5.23 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 7 | 2 |
| Target Price | $0.83 | ★ $18.50 |
| AVG Volume (30 Days) | ★ 34.0M | 1.6M |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 6.88% |
| EPS Growth | ★ 24.69 | 20.90 |
| EPS | N/A | ★ 1.03 |
| Revenue | ★ $275,496,000.00 | N/A |
| Revenue This Year | N/A | $1.17 |
| Revenue Next Year | $1.36 | N/A |
| P/E Ratio | ★ N/A | $5.31 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.40 | $2.77 |
| 52 Week High | $15.20 | $15.55 |
| Indicator | BYND | EMBC |
|---|---|---|
| Relative Strength Index (RSI) | 88.60 | 69.08 |
| Support Level | $0.66 | $3.01 |
| Resistance Level | N/A | $9.38 |
| Average True Range (ATR) | 0.76 | 0.37 |
| MACD | 1.53 | 0.09 |
| Stochastic Oscillator | 95.81 | 81.21 |
Beyond Meat Inc is a provider of plant-based meat company offering a portfolio of revolutionary plant-based meats. It builds meat directly from plants, an innovation that enables consumers to experience the taste, texture and other sensory attributes of popular animal-based meat products while enjoying the nutritional and environmental benefits of eating plant-based meat product It has products such as burgers, sausage, ground beef, jerky, meatballs and chicken. The company generates revenue from sales of its products to the customers across mainstream grocery, mass merchandiser, club store, convenience store and natural retailer channels and various food-away-from-home channels, including restaurants, foodservice outlets and schools, mainly in the United States.
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.